Article
CHST6 mutations identified in Iranian MCD patients and CHST6 mutations reported worldwide identify targets for gene editing approaches including the CRISPR/Cas system.
International ophthalmology - 1 Sept 2020
Safari Iman, Baradaran-Rafii Alireza, Issazadeh-Navikas Shohreh, Elahi Elahe
Abstract excerpt
PURPOSE: To identify CHST6 mutations in Iranians macular corneal dystrophy (MCD) patients and also to assess distribution of amino acids in the encoded protein that are affected by CHST6 mutations reported hitherto in various populations in order to predict gene regions that may be appropriate targets for gene editing approaches including the CRISPR/Cas system. The analysis will also reveal biologically and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
